SANOFI US SERVICES INC.

Lobbying for SANOFI US SERVICES INC

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $1,590,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 17

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 5376
Impacts and Outcomes for Health Career Training Act
HR 7834
Safe Cloud Storage Act
S 864
HELP Copays Act
S 2027
Prescription Information Modernization Act of 2025
S 899
Producer and Agricultural Credit Enhancement Act of 2025
HR 3656
To amend the Agricultural Research, Extension, and Education Reform Act of 1998 to authorize the Secretary of Agricultu…
S 43
Skinny Labels, Big Savings Act
HR 7174
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 1503
Prescription Information Modernization Act of 2023
HR 2880
Protecting Patients Against PBM Abuses Act
HR 5539
ORPHAN Cures Act
S 1339
Pharmacy Benefit Manager Reform Act
S 1375
HELP Copays Act
S 1542
DRUG Act
S 4504
SCREEN for Type 1 Diabetes Act of 2024
HR 8698
SCREEN for Type 1 Diabetes Act of 2024

Lobbying activity 6

Manufacturing

Insulin; Taxes- General Issues; Vaccine - General Issues; Pharmacy Benefits Managers (PBMs); and Type 1 Diabetes Screening.

Health Issues

340B: Biologic/Small molecule drug negotiation eligibility within HR 7174; EPIC Act; CDC Type 1 Diabetes Awareness and Education within LHHS appropriations; Clinical Trial Diversity; Copay Accumulators; COPD Education and Awareness within LHHS appropriations; COPD Research Funding within LHHS appropriations; Delinking; Drug Price Negotiations within Inflation Reduction Act; Drug Pricing- General Issues; FDA Drug Development; FDA Issues - General; issues related to HR 1 One Big Beautiful Bill; HR 1503: Prescription Information Modernization Act of 2023; HR 2880: Protecting Patients Against PBM Abuses Act; HR 5376: Inflation Reduction Act; HRSA - Type 1 Diabetes Screening within LHHS appropriations; Influenza Vaccines; Insurance Design; Intellectual Property; International Reference Pricing; Most Favored Nation; Orphan Drug Negotiation within HR 5539/S 3131 Orphan Cures Act; Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization; Pharmacy Benefit Managers (PBM) Reform; Rare Pediatric Priority Review Voucher Program Reauthorization within HR 7834; Rebate Pass Through; Respiratory Syncytial Virus (RSV) Access; Routine Immunization Rates; S. 864 HELP Copays Act: S. 1339: PBM Reform Act; S. 1375 S. 1542: DRUG Act; S. 2027: Prescription Information Modernization Act; S.4504 / HR 8698 (118th): SCREEN for Type 1 Diabetes Act; Supply Chain; Tax Credits; Transplant; Vaccine Injury Compensation Program; Vaccines-General Issues.

Medicare/Medicaid

340B; Medicare Negotiation, and Most Favored Nation.

Trade (domestic/foreign)

Supply Chain Issues; and Importation issues.

Taxation/Internal Revenue Code

S. 899 One Big Beautiful Bill: BEAT, FDII, GILTI, and Tax Cuts and Job Acts; TRIP Waivers; HR 3656 (117th): Vaccine Injury Compensation Program.

S. 43: Skinny Labels, Big Savings Act; ETHIC Act; and Intellectual Property.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.